Piper Jaffray Downgrades ABI After Firm Reports Fiscal Q4 Earnings | GenomeWeb

Piper Jaffray Downgrades ABI After Firm Reports Fiscal Q4 Earnings

Jul 28, 2006

NEW YORK (GenomeWeb News) — Piper Jaffray yesterday downgraded shares in Applied Biosystems to “Market Perform” from “Outperform” after the company reported its fiscal fourth-quarter earnings.

As GenomeWeb News reported yesterday, ABI said that fiscal fourth-quarter revenue increased 9 percent as real-time PCR and mass spec jumped and DNA sequencing slid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.